Savara
SVRA
#6060
Rank
โ‚ฌ0.97 B
Marketcap
4,77ย โ‚ฌ
Share price
-1.45%
Change (1 day)
108.11%
Change (1 year)

Earnings for Savara (SVRA)

Earnings in 2026 (TTM): -โ‚ฌ0.12 Billion

According to Savara's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of -โ‚ฌ0.11 Billion a decrease over its 2024 earnings that were of -โ‚ฌ84.29 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Savara from 2002 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -โ‚ฌ0.12 Billion5.9%
2025 -โ‚ฌ0.11 Billion23.94%
2024 -โ‚ฌ84.29 Million75.29%
2023 -โ‚ฌ48.09 Million43.38%
2022 -โ‚ฌ33.54 Million-11.31%
2021 -โ‚ฌ37.82 Million-13.3%
2020 -โ‚ฌ43.62 Million-36.53%
2019 -โ‚ฌ68.73 Million13.76%
2018 -โ‚ฌ60.41 Million105.54%
2017 -โ‚ฌ29.4 Million34.11%
2016 -โ‚ฌ21.92 Million-37.43%
2015 -โ‚ฌ35.03 Million38.81%
2014 -โ‚ฌ25.24 Million33.62%
2013 -โ‚ฌ18.89 Million38.49%
2012 -โ‚ฌ13.64 Million24.59%
2011 -โ‚ฌ10.95 Million-36.5%
2010 -โ‚ฌ17.24 Million-3.14%
2009 -โ‚ฌ17.8 Million-23.28%
2008 -โ‚ฌ23.2 Million8.52%
2007 -โ‚ฌ21.38 Million-34.14%
2006 -โ‚ฌ32.46 Million184.43%
2005 -โ‚ฌ11.41 Million90.75%
2004 -โ‚ฌ5.99 Million190.35%
2003 -โ‚ฌ2.07 Million11.64%
2002 -โ‚ฌ1.85 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
OPKO Health
OPK
-โ‚ฌ0.21 Billion 76.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
-โ‚ฌ15.97 Million-85.98%๐Ÿ‡บ๐Ÿ‡ธ USA